□Patients with atrial fibrillation are prone to thrombosis which will cause stroke and other embolic diseases. Rivaroxaban is a direct Factor Xa inhibitor, which can reduce thrombin production and inhibit thrombosis. This evidence concerns the gene F10 and stroke disorder.